Notícias Eulerpool Kyowa Kirin Co

Kyowa Kirin Co Eulerpool-AFX

Kyowa Kirin Co Notícias de ações

Kyowa Kirin Co é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Kyowa Kirin Co nós reunimos aqui.

• 17 de junho ·

  SeekingAlpha
  Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare
• 10 de junho ·

  Yahoo
  Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
• 8 de maio ·

  Yahoo
  Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
• 15 de abril ·

  Yahoo
  First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
• 15 de abril ·

  Yahoo
  First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
• 2 de abril ·

  Yahoo
  Kyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
• 8 de março ·

  Yahoo
  Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024
• 14 de fevereiro ·

  Yahoo
  Kyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 Meeting
• 7 de fevereiro ·

  Yahoo
  BridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japan
• 6 de fevereiro ·

  Yahoo
  Kyowa Kirin Announces First Patient Enrolled in the Phase 2 Clinical Trial Evaluating Tivozanib Eye Drops in Patients with Diabetic Macular Edema